The spinal column in psoriatic arthritis and in psoriasis without arthritis
Zbojanová, M.; Trnavský, K.; Schultz, P.; Vlcek, F.
Bratislavske Lekarske Listy 75(5): 567-576
1981
ISSN/ISBN: 0006-9248 PMID: 7237186 Document Number: 182378
Document emailed within 1 workday
Related Documents
Cohen, M.R.; Reda, D.J.; Clegg, D.O. 1999: Baseline relationships between psoriasis and psoriatic arthritis: analysis of 221 patients with active psoriatic arthritis. Department of Veterans Affairs Cooperative Study Group on Seronegative Spondyloarthropathies Journal of Rheumatology 26(8): 1752-1756Patrizi, A.; Venturi, M.; Scorzoni, R.; Pazzaglia, M.; Malavolta, N.; Bardazzi, F. 2014: Nail dystrophies, scalp and intergluteal/perianal psoriatic lesions: risk factors for psoriatic arthritis in mild skin psoriasis? Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 149(2): 177-184
Lindqvist, U.; Wernroth, M.-L.; Husmark, T.; Larsson, P.; Geijer, M.; Teleman, A.; Theander, E.; Alenius, G.-M. 2017: DAPSA, DAS28 and MDA predict long-term treatment regime in psoriatic arthritis. the Swedish Early Psoriatic Arthritis Cohort Clinical and Experimental Rheumatology 35(6): 936-942
Henno, A.; Rausin, A.; Malaise, M.; de la Brassinne, M. 2006: Psoriasis and psoriatic arthritis Revue Medicale de Liege 61(5-6): 334-340
Boehncke, W.-H.; Adebajo, A.; Cauli, A.; Nash, P.; Salvarani, C.; Kavanaugh, A.F. 2008: Initiative for quality in psoriasis and psoriatic arthritis Journal of Rheumatology 35(7): 1431-1433
Jajić, I.; Kastelan, A.; Brnobić, A.; Kerhin-Brkljacić, V.; Cecuk, L. 1977: Frequency of the HLA antigens in psoriatic arthritis and psoriasis Lijecnicki Vjesnik 99(5): 279-284
Maso, G.; Baggio, B.; Tonon, R.; Fiocco, U.; Gambari, P.F.; Todesco, S. 1983: Fructose-induced hyperuricemia in psoriasis and psoriatic arthritis Clinical and Experimental Rheumatology 1(2): 149-151
Mortel, M.R.; Emer, J. 2010: Prospective new biologic therapies for psoriasis and psoriatic arthritis Journal of Drugs in Dermatology: Jdd 9(8): 947-958
Zaghi, D.; Krueger, G.G.; Callis Duffin, K. 2012: Ustekinumab: a review in the treatment of plaque psoriasis and psoriatic arthritis Journal of Drugs in Dermatology: Jdd 11(2): 160-167
Ventura, M.; Colizzi, M.; Ottolenghi, A.; Polignano, A.; Sinisi, D.A.; Rantuccio, F.; Antonaci, S.; Bonomo, L. 1989: Cell-mediated immune response in psoriasis and psoriatic arthritis Recenti Progressi in Medicina 80(9): 449-454
2012: Update on current care guidelines: psoriasis and psoriatic arthritis Duodecim; Laaketieteellinen Aikakauskirja 128(15): 1620-1621
Petty, R.E. 1994: Juvenile psoriatic arthritis, or juvenile arthritis with psoriasis? Clinical and Experimental Rheumatology 12(Suppl 10): S55-S58
Forman, S.B.; Higginson, R.; Garrett, A.B. 2008: Psoriasis and psoriatic arthritis in a patient with HIV: response to mycophenolate mofetil treatment Journal of Drugs in Dermatology: Jdd 7(10): 972-973
Henderson Berg, M.-H.; Carrasco, D. 2017: Injection Site Reactions to Biologic Agents Used in Psoriasis and Psoriatic Arthritis Journal of Drugs in Dermatology: Jdd 16(7): 695-698
Scarpa, R.; Manguso, F.; D'Arienzo, A.; D'Armiento, F.P.; Astarita, C.; Mazzacca, G.; Ayala, F. 2000: Microscopic inflammatory changes in colon of patients with both active psoriasis and psoriatic arthritis without bowel symptoms Journal of Rheumatology 27(5): 1241-1246
Polachek, A.; Korobko, U.; Mader-Balakirski, N.; Arad, U.; Levartovsky, D.; Kaufman, I.; Anouk, M.; Litinsky, I.; Wigler, I.; Mendelson, E.; Paran, D.; Matz, H.; Caspi, D.; Mandelboim, M.; Elkayam, O. 2015: Immunogenicity and safety of vaccination against seasonal 2012 influenza virus among patients with psoriatic arthritis and psoriasis Clinical and Experimental Rheumatology 33(2): 181-186
Jaller Char, J.J.; Jaller, J.A.; Waibel, J.S.; Bhanusali, D.G.; Bhanusali, N. 2018: The Role of IL-17 in the Human Immune System and its Blockage as a Treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Journal of Drugs in Dermatology: Jdd 17(5): 539-542
Korendowych, E.; Dixey, J.; Cox, B.; Jones, S.; McHugh, N. 2003: The Influence of the HLA-DRB1 rheumatoid arthritis shared epitope on the clinical characteristics and radiological outcome of psoriatic arthritis Journal of Rheumatology 30(1): 96-101
Rathod, D.; Weinberg, J.M..; Yamauchi, P.S..; Kircik, L.H..; Wollina, U.; Lotti, T.; Goldust, M. 2019: Successful Treatment of Refractory Plaque-Type Psoriasis and Psoriatic Arthritis With Guselkumab and Adalimumab Combination Therapy: A Case Report Journal of Drugs in Dermatology: Jdd 18(4): 394-396
Manara, M.; Caporali, R.; Favalli, E.G.; Grosso, V.; Atzeni, F.; Sarzi Puttini, P.; Gorla, R.; Bazzani, C.; Fusaro, E.; Pellerito, R.; Rocchetta, P.A.; Sinigaglia, L. 2017: Two-year retention rate of golimumab in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: data from the LORHEN registry Clinical and Experimental Rheumatology 35(5): 804-809